Daytrana

DRUG2 trials

Sponsors

Noven Therapeutics, Cox Health Systems

Conditions

Attention Deficit Hyperactivity DisorderINSOMNIA

Phase 4

Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

CompletedNCT00434213

Noven TherapeuticsAttention Deficit Hyperactivity Disorder

Start: 2007-01-31End: 2008-07-31Updated: 2017-04-26

Unknown Phase

Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHD

CompletedNCT00989950

Cox Health SystemsAttention Deficit Hyperactivity Disorder, INSOMNIA

Start: 2009-12-31End: 2011-02-28Updated: 2012-07-19

Related Papers

Methylphenidate transdermal system: a multisite, open-label study of dermal reactions in pediatric patients diagnosed with ADHD.

2010-01-013 citations